Clinical Trial Update: 1-year Clinical Outcomes in Recombinant Tissue Plasminogen Activator (Rt-PA) Treated Chinese Acute Ischaemic Stroke (AIS) Patients

View source ↗

Summary

1-year clinical outcomes from a Boehringer Ingelheim-sponsored study of recombinant tissue plasminogen activator (alteplase) in Chinese patients with acute isch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Stroke | Status: COMPLETED | Results posted: 2024-10-16